Susanna C Byram1,2,3, Samantha E Bialek2,3, Vicki A Husak2, Daniel Balcarcel3, James Park3, Jacquelyn Dang3, Eileen M Foecking2,4. 1. Department of Anesthesiology, Loyola University Medical Center, Maywood, IL, Byram - current, USA. 2. Research Service, Department of Veterans Affairs, Edward Hines Jr. VA Hospital, Hines, IL, USA. 3. Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA. 4. Department of Otolaryngology-Head and Neck Surgery, Loyola University Medical Center, Maywood, IL, USA.
Abstract
BACKGROUND: Local anesthetic toxicity has been well-documented to cause neuronal injury, death, and dysfunction, particularly in a susceptible nerve. OBJECTIVE: To determine whether select local anesthetics affect neuron survival and/or functional recovery of an injured nerve. METHODS: This report describes 6 separate experiments that test immediate or delayed application of local anesthetics in 3 nerve injury models. Adult C57/black6 male mice underwent a facial nerve sham, transection, or crush injury. Local anesthetic or saline was applied to the facial nerve at the time of injury (immediate) or 1 day after injury (delayed). Average percent facial motoneuron (FMN) survival was evaluated four-weeks after injury. Facial nerve regeneration was estimated by observing functional recovery of eye blink reflex and vibrissae movement after facial nerve crush injury. RESULTS: FMN survival after: transection + immediate treatment with ropivacaine (54.8%), bupivacaine (63.2%), or tetracaine (66.9%) was lower than saline (85.5%) and liposomal bupivacaine (85.0%); crush + immediate treatment with bupivacaine (92.8%) was lower than saline (100.7%) and liposomal bupivacaine (99.3%); sham + delayed treatment with bupivacaine (89.9%) was lower than saline (96.6%) and lidocaine (99.5%); transection + delayed treatment with bupivacaine (67.3%) was lower than saline (78.4%) and liposomal bupivacaine (77.6%); crush + delayed treatment with bupivacaine (85.3%) was lower than saline (97.9%) and lidocaine (96.0%). The average post-operative time for mice to fully recover after: crush + immediate treatment with bupivacaine (12.83 days) was longer than saline (11.08 days) and lidocaine (10.92 days); crush + delayed treatment with bupivacaine (16.79 days) was longer than saline (12.73 days) and lidocaine (11.14 days). CONCLUSIONS: Our data demonstrate that some local anesthetics, but not all, exacerbate motoneuron death and delay functional recovery after a peripheral nerve injury. These and future results may lead to clinical strategies that decrease the risk of neural deficit following peripheral nerve blocks with local anesthetics.
BACKGROUND: Local anesthetic toxicity has been well-documented to cause neuronal injury, death, and dysfunction, particularly in a susceptible nerve. OBJECTIVE: To determine whether select local anesthetics affect neuron survival and/or functional recovery of an injured nerve. METHODS: This report describes 6 separate experiments that test immediate or delayed application of local anesthetics in 3 nerve injury models. Adult C57/black6 male mice underwent a facial nerve sham, transection, or crush injury. Local anesthetic or saline was applied to the facial nerve at the time of injury (immediate) or 1 day after injury (delayed). Average percent facial motoneuron (FMN) survival was evaluated four-weeks after injury. Facial nerve regeneration was estimated by observing functional recovery of eye blink reflex and vibrissae movement after facial nerve crush injury. RESULTS: FMN survival after: transection + immediate treatment with ropivacaine (54.8%), bupivacaine (63.2%), or tetracaine (66.9%) was lower than saline (85.5%) and liposomal bupivacaine (85.0%); crush + immediate treatment with bupivacaine (92.8%) was lower than saline (100.7%) and liposomal bupivacaine (99.3%); sham + delayed treatment with bupivacaine (89.9%) was lower than saline (96.6%) and lidocaine (99.5%); transection + delayed treatment with bupivacaine (67.3%) was lower than saline (78.4%) and liposomal bupivacaine (77.6%); crush + delayed treatment with bupivacaine (85.3%) was lower than saline (97.9%) and lidocaine (96.0%). The average post-operative time for mice to fully recover after: crush + immediate treatment with bupivacaine (12.83 days) was longer than saline (11.08 days) and lidocaine (10.92 days); crush + delayed treatment with bupivacaine (16.79 days) was longer than saline (12.73 days) and lidocaine (11.14 days). CONCLUSIONS: Our data demonstrate that some local anesthetics, but not all, exacerbate motoneuron death and delay functional recovery after a peripheral nerve injury. These and future results may lead to clinical strategies that decrease the risk of neural deficit following peripheral nerve blocks with local anesthetics.
Authors: Philipp Lirk; Ingrid Haller; Hans Peter Colvin; Leopold Lang; Bettina Tomaselli; Lars Klimaschewski; Peter Gerner Journal: Anesth Analg Date: 2008-05 Impact factor: 5.108
Authors: Hila Epstein-Barash; Iris Shichor; Albert H Kwon; Sherwood Hall; Michael W Lawlor; Robert Langer; Daniel S Kohane Journal: Proc Natl Acad Sci U S A Date: 2009-04-13 Impact factor: 11.205
Authors: Nicole M Geremia; Tessa Gordon; Thomas M Brushart; Abdulhakeem A Al-Majed; Valerie M K Verge Journal: Exp Neurol Date: 2007-02-21 Impact factor: 5.330
Authors: Ingrid Haller; Barbara Hausott; Bettina Tomaselli; Christian Keller; Lars Klimaschewski; Peter Gerner; Philipp Lirk Journal: Anesthesiology Date: 2006-11 Impact factor: 7.892
Authors: M Damjanovska; E Cvetko; A Hadzic; A Seliskar; T Plavec; K Mis; I Vuckovic Hasanbegovic; T Stopar Pintaric Journal: Anaesthesia Date: 2015-09-04 Impact factor: 6.955
Authors: Joseph M Neal; Michael J Barrington; Richard Brull; Admir Hadzic; James R Hebl; Terese T Horlocker; Marc A Huntoon; Sandra L Kopp; James P Rathmell; James C Watson Journal: Reg Anesth Pain Med Date: 2015 Sep-Oct Impact factor: 6.288
Authors: Nagalingeswaran Ahilasamy; Rajendran Dinesh Kumar; Hem Anand Nayagam; Omprakash Shanmuganandam; K R Vaibhavi; Vishakha Modak Journal: Indian J Otolaryngol Head Neck Surg Date: 2021-01-04